GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin
Weight gain and obesity are global health concerns contributing to morbidity with increased risks of cardiovascular disease, diabetes, liver steatohepatitis and cancer. Pharmacological therapies or bariatric surgery are often required for those who fail to adhere to diet and lifestyle modifications....
Main Authors: | Jing Ouyang, Stéphane Isnard, John Lin, Brandon Fombuena, Xiaorong Peng, Yaokai Chen, Jean-Pierre Routy |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2020.581839/full |
Similar Items
-
Metformin effect on gut microbiota: insights for HIV-related inflammation
by: Jing Ouyang, et al.
Published: (2020-03-01) -
Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment
by: Jing Ouyang, et al.
Published: (2020-09-01) -
Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System
by: Xiaorong Peng, et al.
Published: (2020-12-01) -
Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection
by: Jing Ouyang, et al.
Published: (2020-08-01) -
The Bacterium Akkermansia muciniphila: A Sentinel for Gut Permeability and Its Relevance to HIV-Related Inflammation
by: Jing Ouyang, et al.
Published: (2020-04-01)